CollPlant Biotechnologies
CLGN
7 hedge funds and large institutions have $7.42M invested in CollPlant Biotechnologies in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
18% more capital invested
Capital invested by funds: $6.28M → $7.42M (+$1.14M)
17% more funds holding
Funds holding: 6 → 7 (+1)
4.04% more ownership
Funds ownership: 9.72% → 13.76% (+4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$1.13M |
| 2 |
IMOV
Investment Management of Virginia
Richmond,
Virginia
|
+$900K |
| 3 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$225K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$98.6K |
| 5 |
Renaissance Technologies
New York
|
+$900 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
| $4.57M | +$1.13M | +125,958 | +30% |
|
|
IMOV
2
Investment Management of Virginia
Richmond,
Virginia
| $2.29M | +$900K | +100,000 | +57% |
|
|
SDJVC
3
St. Denis J. Villere & Co
New Orleans,
Louisiana
| $356K | +$225K | +25,000 | +140% |
|
|
4
Renaissance Technologies
New York
| $107K | +$900 | +100 | +0.8% |
|
|
5
Citadel Advisors
Miami,
Florida
| $88K | +$98.6K | +10,966 | New |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $7K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $2K | -$3.8K | -422 | -61% |
|
CLGN Hedge Fund Activity: Q3 2020 in Review
7 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q3 2020, worth a combined $7.42M — up 18% from $6.28M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CLGN positions and 0 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Meitav Investment House, adding an estimated $1.13M. The largest seller was UBS Group, cutting an estimated $3.8K.
- 7 institutional investors held CollPlant Biotechnologies (CLGN) as of Q3 2020, up from 6 in Q2 2020.
- Funds reported $7.42M of CollPlant Biotechnologies stock for Q3 2020, up 18% quarter-over-quarter.
- 1 fund opened new CollPlant Biotechnologies positions in Q3 2020 and 0 closed out, a net change of +1 holder.
- The largest CollPlant Biotechnologies buyer in Q3 2020 was Meitav Investment House, an estimated $1.13M added.
- The largest CollPlant Biotechnologies seller in Q3 2020 was UBS Group, an estimated $3.8K sold.
Based on aggregated 13F filings for Q3 2020.